NHSN

Orchard Software Announces New Electronic Support for Antimicrobial Stewardship

Retrieved on: 
Thursday, April 4, 2024
Public health, Data analysis, NHSN, Hospital, HL7, Antimicrobial stewardship, Infection, CDC, Orchard

CARMEL, Ind., April 4, 2024 /PRNewswire/ -- Today, Orchard Software announced the availability of Antimicrobial Use and Resistance (AUR) reporting to the National Healthcare Safety Network (NHSN) , which supports regulatory requirements and antimicrobial stewardship endeavors.

Key Points: 
  • CARMEL, Ind., April 4, 2024 /PRNewswire/ -- Today, Orchard Software announced the availability of Antimicrobial Use and Resistance (AUR) reporting to the National Healthcare Safety Network (NHSN) , which supports regulatory requirements and antimicrobial stewardship endeavors.
  • AUR reporting and data analysis promotes antimicrobial stewardship and impedes the transmission of resistant pathogens.
  • "At Orchard, we are continually looking for ways to support our customers and the valuable work they do.
  • Adding AUR reporting is one more way that we can provide superior support to our customers," said Billie Whitehurst, CEO of Orchard Software.

Infectious Disease Connect’s ILÚM Insight Receives CDC Certification as a Validated Antimicrobial Use Reporting Solution

Retrieved on: 
Thursday, August 3, 2023
Antimicrobial stewardship, Centers for Medicare & Medicaid Services, Clinical Document Architecture, SDS, Calendar, AUR, Infection, ID, CDSS, Certification, CDA, Medicare, Hospital, Entrepreneurship, Health, AU, Software, Nursing, NHSN

PITTSBURGH, Aug. 03, 2023 (GLOBE NEWSWIRE) -- (August 3, 2023) – Infectious Disease Connect announced today that its antimicrobial stewardship clinical decision support solution (CDSS), ILÚM Insight®, has been named an official National Healthcare Safety Network (NHSN) Validated Antimicrobial Use and Reporting (AUR) Solution.

Key Points: 
  • PITTSBURGH, Aug. 03, 2023 (GLOBE NEWSWIRE) -- (August 3, 2023) – Infectious Disease Connect announced today that its antimicrobial stewardship clinical decision support solution (CDSS), ILÚM Insight®, has been named an official National Healthcare Safety Network (NHSN) Validated Antimicrobial Use and Reporting (AUR) Solution.
  • With this certification, ILÚM Insight can now be used as a Clinical Document Architecture (CDA) Implementor to complete all newly required NHSN AUR Module reporting.
  • “We are proud to have achieved NHSN AU SDS validation for Insight” said Riaan Erwee, Chief Operating Officer, Infectious Disease Connect.
  • “The clinical decision support ILÚM Insight provides is extremely useful for many of our clients in combatting antimicrobial resistance, better managing infectious diseases (ID), and improving patient care.

KLAS Research ranks Wolters Kluwer’s Sentri7 #1 for Infection Control & Monitoring for second year

Retrieved on: 
Wednesday, February 8, 2023
Technology, Infectious Diseases, Other Technology, Health Technology, Software, Other Health, Health, General Health, Data Management, Patient safety, Hospital, Wolters Kluwer, Workflow, Fungal infection, Culture, Infection, Workload, Patient, Research, NHSN, Student, Public health surveillance, EHR, CMS, Learning, COVID-19, Microsoft Excel, Pharmaceutical industry, Nursing, KLAS

Wolters Kluwer Health today announced that KLAS Research has recognized the Sentri7® clinical surveillance solution as Best in KLAS® for infection control and monitoring for the second year in a row in the 2023 Best in KLAS: Software and Services report .

Key Points: 
  • Wolters Kluwer Health today announced that KLAS Research has recognized the Sentri7® clinical surveillance solution as Best in KLAS® for infection control and monitoring for the second year in a row in the 2023 Best in KLAS: Software and Services report .
  • KLAS Research , which specializes in monitoring and reporting the performance of healthcare vendors, rated Sentri7 as the market leader for infection control for hospitals and health systems.
  • We’re proud of our partner hospitals using Sentri7 to help address their evolving infection prevention needs during these difficult times."
  • The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Juvare® Announces Automation of Data from EMResource® to CDC's NHSN

Retrieved on: 
Wednesday, December 21, 2022
Government, HHS, Health, NHSN, COVID-19, CDC, JX, Korea Disease Control and Prevention Agency, Public health, Chief Technology Officer of the United States, Automation, API, Public sector, Hospital, Pharmaceutical industry, Risk management

ATLANTA, Dec. 21, 2022 /PRNewswire/ -- Juvare, the leader in crisis and emergency management technology, today announced the successful automation of hospital bed capacity data from EMResource to the National Healthcare Safety Network (NHSN), directed by the Centers for Disease Control and Prevention (CDC), to support the shift in federal data collection responsibilities for data relating to COVID-19.

Key Points: 
  • ATLANTA, Dec. 21, 2022 /PRNewswire/ -- Juvare , the leader in crisis and emergency management technology, today announced the successful automation of hospital bed capacity data from EMResource to the National Healthcare Safety Network (NHSN), directed by the Centers for Disease Control and Prevention (CDC), to support the shift in federal data collection responsibilities for data relating to COVID-19.
  • Throughout the pandemic, the national response to COVID-19 has leveraged data from EMResource to enable flexible data collection from hospitals and improved visibility at the state and federal levels.
  • Data from EMResource is estimated to have been the single largest source of hospital data.
  • As the need to connect various data streams increases, JX Connector is uniquely poised to assist public health stakeholders in responding to various threats and incidents."

RosettaHealth Achieves Electronic Health Record Exchange and Interoperability Milestones in 2021

Retrieved on: 
Tuesday, December 7, 2021
Health, Technology, Parent, Growth, Mehin, Record, NHSN, Laika (EHR testing framework), CEO, CMS, Organization, Contract, NICU, COVID-19, HI, Solution, Hospital, Health information exchange, Software as a service, Pharmaceutical industry, Food delivery

WASHINGTON, Dec. 7, 2021 /PRNewswire-PRWeb/ -- RosettaHealth, an innovative and secure, big health data interoperability platform, today announced that it achieved significant growth, new implementation milestones and new accreditations in 2021.

Key Points: 
  • WASHINGTON, Dec. 7, 2021 /PRNewswire-PRWeb/ -- RosettaHealth, an innovative and secure, big health data interoperability platform, today announced that it achieved significant growth, new implementation milestones and new accreditations in 2021.
  • Here are some key 2021 milestones for RosettaHealth:
    Collabrity Health Consortium Launch: Along with Cognosante and HealtHIE Nevada, RosettaHealth became a founding membe r of a new Collabrity Health consortium that enables health information exchange (HIEs) to increase patient access to healthcare through interoperability and accelerate scalability, growth, and innovation.
  • "2021 was a significant year in the overall health IT arena, and clearly health data exchange continues to be pushed to the forefront of healthcare," said Buff Colchagoff, CEO of RosettaHealth.
  • The RosettaHealth platform is making electronic health record exchange affordable and ubiquitous.

What can $2.1 billion do for infection control in the wake of COVID-19?

Retrieved on: 
Monday, September 20, 2021
White House, Federal Government, Public Policy, Government, Healthcare Reform, Health, Public Policy, General Health, Infection, Compliance, Interview, Solution, IPC, White House, Lawyer, Student, Patient, NHSN, Dialysis, LinkedIn, Hospital, Centers for Disease Control and Prevention, CDC, Nursing, Public health, Center, CIC, MPH, White, Risk, COVID-19, Research, Learning, Data collection, Antibiotic, WKL, Pharmaceutical industry, Medicine

What: The Center for Disease Control and Prevention (CDC) announced on Friday that the agency will be investing $2.1 billion to improve infection prevention and control activities across the U.S. public health and healthcare sectors.

Key Points: 
  • What: The Center for Disease Control and Prevention (CDC) announced on Friday that the agency will be investing $2.1 billion to improve infection prevention and control activities across the U.S. public health and healthcare sectors.
  • Why: The investment will allow the United States to improve public health and the quality of healthcare, including addressing healthcare-related inequities.
  • The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide.
  • For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth .